{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:05:23Z","timestamp":1780661123969,"version":"3.54.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00115-024-01722-5","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T16:02:35Z","timestamp":1723478555000},"page":"781-796","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabiskonsum und Cannabiskonsumst\u00f6rungen","Cannabis use and cannabis use disorders"],"prefix":"10.1007","volume":"95","author":[{"given":"E.","family":"Hoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. W.","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"1722_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","volume":"2","author":"JC Anthony","year":"1994","unstructured":"Anthony\u00a0JC, Warner\u00a0LA, Kessler\u00a0RC (1994) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity survey. Exp Clin Psychopharmacol 2:244\u2013268","journal-title":"Exp Clin Psychopharmacol"},{"issue":"2","key":"1722_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00787-023-02173-0","volume":"33","author":"N Arnaud","year":"2024","unstructured":"Arnaud\u00a0N, Wartberg\u00a0L, Simon-Kutscher\u00a0K, Thomasius\u00a0R (2024) IMAC-Mind Consortium. Prevalence of substance use disorders and associations with mindfulness, impulsive personality traits and psychopathological symptoms in a\u00a0representative sample of adolescents in Germany. Eur Child Adolesc Psychiatry 33(2):451\u2013465 (Feb)","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1722_CR3","doi-asserted-by":"publisher","first-page":"e202370","DOI":"10.1001\/jamanetworkopen.2020.2370","volume":"3","author":"A Bahji","year":"2020","unstructured":"Bahji\u00a0A, Stephenson\u00a0C, Tyo\u00a0R, Hawken\u00a0ER, Seitz\u00a0DP (2020) Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a\u00a0systematic review and meta-analysis. JAMA Netw Open 3:e202370","journal-title":"JAMA Netw Open"},{"key":"1722_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41583-021-00465-5","volume":"22","author":"A Bara","year":"2021","unstructured":"Bara\u00a0A, Ferland\u00a0JN, Rompala\u00a0G et\u00a0al (2021) Cannabis and synaptic reprogramming of the developing brain. Nat Rev Neurosci 22:423\u2013438","journal-title":"Nat Rev Neurosci"},{"key":"1722_CR5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1038\/npp.2014.67","volume":"39","author":"G Battistella","year":"2014","unstructured":"Battistella\u00a0G, Fornari\u00a0E, Annoni\u00a0JM et\u00a0al (2014) Long-term effects of cannabis on brain structure. Neuropsychopharmacology 39:2041\u20132048","journal-title":"Neuropsychopharmacology"},{"key":"1722_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/1073858417707457","volume":"24","author":"G Bayraktar","year":"2018","unstructured":"Bayraktar\u00a0G, Kreutz\u00a0MR et\u00a0al (2018) Neuronal DNA methyltransferases: epigenetic mediators between synaptic activity and gene expression? Neuroscientist 24:171\u2013185","journal-title":"Neuroscientist"},{"key":"1722_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/adb.12370","volume":"22","author":"L Blanco-Hinojo","year":"2017","unstructured":"Blanco-Hinojo\u00a0L, Pujol\u00a0J, Harrison\u00a0BJ et\u00a0al (2017) Attenuated frontal and sensory inputs to the basal ganglia in cannabis users. Addict Biol 22:1036\u20131047","journal-title":"Addict Biol"},{"key":"1722_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3389\/fpsyt.2020.00859","volume":"11","author":"G Blest-Hopley","year":"2020","unstructured":"Blest-Hopley\u00a0G, Colizzi\u00a0M, Giampietro\u00a0V et\u00a0al (2020) Is the adolescent brain at greater vulnerability to the effects of cannabis? A\u00a0narrative review of the evidence. Front Psychiatry 11:859","journal-title":"Front Psychiatry"},{"key":"1722_CR9","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neuroimage.2005.02.012","volume":"26","author":"KI Bolla","year":"2005","unstructured":"Bolla\u00a0KI, Eldreth\u00a0DA, Matochik\u00a0JA et\u00a0al (2005) Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26:480\u2013492","journal-title":"Neuroimage"},{"key":"1722_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0306-4522(97)00348-5","volume":"82","author":"NE Buckley","year":"1998","unstructured":"Buckley\u00a0NE, Hansson\u00a0S, Harta\u00a0G et\u00a0al (1998) Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82:1131\u20131149","journal-title":"Neuroscience"},{"key":"1722_CR11","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.addbeh.2010.03.019","volume":"35","author":"B Calabria","year":"2010","unstructured":"Calabria\u00a0B, Degenhardt\u00a0L, Briegleb\u00a0C et\u00a0al (2010) Systematic reviews of prospective studies investigating \u201cremission\u201d from amphetamine, cannabis, cocaine and opioid dependence. Addict Behav 35:741\u2013749","journal-title":"Addict Behav"},{"key":"1722_CR12","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/brain\/awl064","volume":"129","author":"L Chang","year":"2006","unstructured":"Chang\u00a0L, Yakupov\u00a0R, Cloak\u00a0C et\u00a0al (2006) Marijuana use is associated with a\u00a0reorganized visual-attention network and cerebellar hypoactivation. Brain 129:1096\u20131112","journal-title":"Brain"},{"key":"1722_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopsych.2015.12.002","volume":"79","author":"SJ Broyd","year":"2016","unstructured":"Broyd\u00a0SJ, van Hell\u00a0HH, Beale\u00a0C et\u00a0al (2016) Acute and chronic effects of cannabinoids on human cognition\u2014a systematic review. Biol Psychiatry 79:557\u2013567","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1722_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00406-018-0976-1","volume":"269","author":"AJ Budney","year":"2019","unstructured":"Budney\u00a0AJ, Sofis\u00a0MJ, Borodovsky\u00a0JT (2019) An update on cannabis use disorder with comment on the impact of policy related to therapeutic and recreational cannabis use. Eur Arch Psychiatry Clin Neurosci 269(1):73\u201386. https:\/\/doi.org\/10.1007\/s00406-018-0976-1","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1722_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.biopsych.2011.10.029","volume":"71","author":"A Cheetham","year":"2012","unstructured":"Cheetham\u00a0A, Allen\u00a0NB, Whittle\u00a0S et\u00a0al (2012) Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a\u00a04-year longitudinal and prospective study. Biol Psychiatry 71:684\u2013692","journal-title":"Biol Psychiatry"},{"issue":"9","key":"1722_CR16","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/acer.13441","volume":"41","author":"T Chung","year":"2017","unstructured":"Chung\u00a0T, Cornelius\u00a0J, Clark\u00a0D, Martin\u00a0C (2017) Greater prevalence of proposed ICD-11 alcohol and cannabis dependence compared to ICD-10, DSM-IV, and DSM\u20115 in treated adolescents. Alcohol Clin Exp Res 41(9):1584\u20131592","journal-title":"Alcohol Clin Exp Res"},{"key":"1722_CR17","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00213-017-4620-y","volume":"234","author":"Y Chye","year":"2017","unstructured":"Chye\u00a0Y, Solowij\u00a0N, Suo\u00a0C et\u00a0al (2017b) Cannabis-related hippocampal volumetric abnormalities specific to subregions in dependent users. Psychopharmacology 234:2149\u20132157 (Berl)","journal-title":"Psychopharmacology"},{"key":"1722_CR18","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00213-017-4606-9","volume":"234","author":"Y Chye","year":"2017","unstructured":"Chye\u00a0Y, Solowij\u00a0N, Ganella\u00a0EP et\u00a0al (2017a) Orbitofrontal and caudate volumes in cannabis users: a\u00a0multi-site mega-analysis comparing dependent versus non-dependent users. Psychopharmacology 234:1985\u20131995","journal-title":"Psychopharmacology"},{"issue":"1","key":"1722_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","volume":"7","author":"JP Connor","year":"2021","unstructured":"Connor\u00a0JP, Stjepanovi\u0107\u00a0D, Le Foll\u00a0B et\u00a0al (2021) Cannabis use and cannabis use disorder. Nat Rev Dis Primers 7(1):16","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"1722_CR20","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/add.15743","volume":"117","author":"JP Connor","year":"2022","unstructured":"Connor\u00a0JP, Stjepanovi\u0107\u00a0D, Budney\u00a0AJ, Le Foll\u00a0B, Hall\u00a0WD (2022) Clinical management of cannabis withdrawal. Addiction 117(7):2075\u20132095","journal-title":"Addiction"},{"key":"1722_CR21","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1016\/j.neuroimage.2011.09.046","volume":"59","author":"J Cousijn","year":"2012","unstructured":"Cousijn\u00a0J, Wiers\u00a0RW, Ridderinkhof\u00a0KR et\u00a0al (2012) Grey matter alterations associated with cannabis use: results of a\u00a0VBM study in heavy cannabis users and healthy controls. Neuroimage 59:3845\u20133851","journal-title":"Neuroimage"},{"key":"1722_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/febs.12125","volume":"280","author":"C D\u2019Addario","year":"2013","unstructured":"D\u2019Addario\u00a0C, Di Francesco\u00a0A, Pucci\u00a0M et\u00a0al (2013) Epigenetic mechanisms and endocannabinoid signaling. FEBS\u00a0J 280:1905\u20131917","journal-title":"FEBS J"},{"issue":"3","key":"1722_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/add.14482","volume":"114","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt\u00a0L, Bharat\u00a0C, Bruno\u00a0R, Glantz\u00a0MD, Sampson\u00a0NA, Lago\u00a0L, WHO World Mental Health Survey Collaborators (2019) Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO\u2019s World Mental Health Surveys. Addiction 114(3):534\u2013552","journal-title":"Addiction"},{"key":"1722_CR24","unstructured":"EMCDDA (2023) European Drug Report 2023: Trends and Developments. https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023_en"},{"key":"1722_CR25","first-page":"26","volume-title":"Diagnostisches und statistisches Manual psychischer St\u00f6rungen DSM","year":"2015","unstructured":"Falkai\u00a0P, Wittchen\u00a0H\u2011U (Hrsg) (2015) Diagnostisches und statistisches Manual psychischer St\u00f6rungen DSM Bd. 5. Hogrefe, S\u00a026\u201327"},{"key":"1722_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41593-020-0611-0","volume":"23","author":"JN Ferland","year":"2020","unstructured":"Ferland\u00a0JN, Hurd\u00a0YL (2020) Deconstructing the neurobiology of cannabis use disorder. Nat Neurosci 23:600\u2013610","journal-title":"Nat Neurosci"},{"issue":"5","key":"1722_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop\u00a0M, Darke\u00a0S, Griffiths\u00a0P et\u00a0al (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90(5):607\u2013614","journal-title":"Addiction"},{"issue":"4","key":"1722_CR28","first-page":"299","volume":"46","author":"S Grover","year":"2004","unstructured":"Grover\u00a0S, Basu\u00a0D (2004) Cannabis and psychopathology : update 2004. Indian J Psychiatry 46(4):299\u2013309","journal-title":"Indian J Psychiatry"},{"key":"1722_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pbb.2017.06.014","volume":"164","author":"Z Guttman","year":"2018","unstructured":"Guttman\u00a0Z, Moeller\u00a0SJ, London\u00a0ED (2018) Neural underpinnings of maladaptive decision-making in addictions. Pharmacol Biochem Behav 164:84\u201398","journal-title":"Pharmacol Biochem Behav"},{"key":"1722_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jep.2007.05.019","volume":"113","author":"A Hazekamp","year":"2007","unstructured":"Hazekamp\u00a0A, Bastola\u00a0K, Rashidi\u00a0H et\u00a0al (2007) Cannabis tea revisited: a\u00a0systematic evaluation of the cannabinoid composition of cannabis tea. J\u00a0Ethnopharmacol 113:85\u201390","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1722_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00115-021-01071-7","volume":"93","author":"A Heinz","year":"2022","unstructured":"Heinz\u00a0A, Halil\u00a0GM, Gutwinski\u00a0S, Beck\u00a0A, Liu\u00a0S (2022) ICD-11: \u00c4nderungen der diagnostischen Kriterien der Substanzabh\u00e4ngigkeit [ICD-11: changes in the diagnostic criteria of substance dependence. Nervenarzt 93(1):51\u201358. https:\/\/doi.org\/10.1007\/s00115-021-01071-7","journal-title":"Nervenarzt"},{"key":"1722_CR32","volume-title":"DHS Jahrbuch Sucht","author":"E Hoch","year":"2024","unstructured":"Hoch\u00a0E, Olderbak\u00a0S, Schwarzkopf\u00a0L, Gomes de Matos\u00a0E, Schneider\u00a0F (2024) Cannabis \u2013 Zahlen und Fakten. In: Deutsche Hauptstelle f\u00fcr Suchtfragen (Hrsg) DHS Jahrbuch Sucht. Pabst, Lengerich"},{"key":"1722_CR33","volume-title":"Praxisbuch Sucht","author":"E Hoch","year":"2022","unstructured":"Hoch\u00a0E, Petersen\u00a0K, Thomasius\u00a0R (2022) Cannabis. In: Batra\u00a0A, Bilke-Hentsch\u00a0O (Hrsg) Praxisbuch Sucht. Thieme, Stuttgart"},{"key":"1722_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-57291-7","volume-title":"Cannabis: Potenzial und Risiko. Eine wissenschaftliche Bestandsaufnahme","author":"E Hoch","year":"2019","unstructured":"Hoch\u00a0E, Friemel\u00a0C, Schneider\u00a0M (2019) Cannabis: Potenzial und Risiko. Eine wissenschaftliche Bestandsaufnahme. Springer Nature, Heidelberg"},{"issue":"16","key":"1722_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3238\/arztebl.2015.0271","volume":"112","author":"E Hoch","year":"2015","unstructured":"Hoch\u00a0E, Bonnet\u00a0U, Thomasius\u00a0R, Ganzer\u00a0F, Havemann-Reinecke\u00a0U, Preuss\u00a0UW (2015) Risks associated with the non-medicinal use of cannabis. Dtsch \u00c4rztebl Int 112(16):271\u2013278. https:\/\/doi.org\/10.3238\/arztebl.2015.0271","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1722_CR36","volume-title":"Modulare Therapie von Cannabisst\u00f6rungen. Das CANDIS-Programm","author":"E Hoch","year":"2011","unstructured":"Hoch\u00a0E, Zimmermann\u00a0P, Henker\u00a0J, Rohrbacher\u00a0H, Noack\u00a0R, B\u00fchringer\u00a0G, Wittchen\u00a0H\u2011U (2011) Modulare Therapie von Cannabisst\u00f6rungen. Das CANDIS-Programm. Hogrefe, G\u00f6ttingen"},{"key":"1722_CR37","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.1523\/JNEUROSCI.1678-17.2017","volume":"37","author":"A Izquierdo","year":"2017","unstructured":"Izquierdo\u00a0A (2017) Functional heterogeneity within rat orbitofrontal cortex in reward learning and decision making. J\u00a0Neurosci 37:10529\u201310540","journal-title":"J Neurosci"},{"issue":"25","key":"1722_CR38","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.2174\/13816128113199990620","volume":"20","author":"L Karila","year":"2014","unstructured":"Karila\u00a0L, Roux\u00a0P, Rolland\u00a0B, Benyamina\u00a0A, Reynaud\u00a0M, Aubin\u00a0HJ, Lan\u00e7on\u00a0C (2014) Acute and long-term effects of cannabis use: a\u00a0review. CPD 20(25):4112\u20134118","journal-title":"CPD"},{"key":"1722_CR39","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1038\/npp.2014.82","volume":"39","author":"H Kober","year":"2014","unstructured":"Kober\u00a0H, DeVito\u00a0EE, DeLeone\u00a0CM et\u00a0al (2014) Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology 39:2288\u20132298","journal-title":"Neuropsychopharmacology"},{"key":"1722_CR40","doi-asserted-by":"publisher","first-page":"e0152482","DOI":"10.1371\/journal.pone.0152482","volume":"11","author":"L Koenders","year":"2016","unstructured":"Koenders\u00a0L, Cousijn\u00a0J, Vingerhoets\u00a0WA et\u00a0al (2016) Grey matter changes associated with heavy cannabis use: a\u00a0longitudinal sMRI study. PLoS ONE 11:e152482","journal-title":"PLoS ONE"},{"key":"1722_CR41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","volume":"3","author":"GF Koob","year":"2016","unstructured":"Koob\u00a0GF, Volkow\u00a0ND (2016) Neurobiology of addiction: a\u00a0neurocircuitry analysis. Lancet Psychiatry 3:760\u2013773","journal-title":"Lancet Psychiatry"},{"key":"1722_CR42","doi-asserted-by":"publisher","first-page":"106479","DOI":"10.1016\/j.addbeh.2020.106479","volume":"109","author":"J Leung","year":"2020","unstructured":"Leung\u00a0J, Chan\u00a0GCK, Hides\u00a0L, Hall\u00a0WD (2020) What is the prevalence and risk of cannabis use disorders among people who use cannabis? a\u00a0systematic review and meta-analysis. Addict Behav 109:106479. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106479","journal-title":"Addict Behav"},{"key":"1722_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1176\/appi.ajp.2018.17040415","volume":"176","author":"S Mackey","year":"2019","unstructured":"Mackey\u00a0S, Allgaier\u00a0N, Chaarani\u00a0B et\u00a0al (2019) Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry 176:119\u2013128","journal-title":"Am J Psychiatry"},{"key":"1722_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/brain.2016.0438","volume":"7","author":"LE Mak","year":"2017","unstructured":"Mak\u00a0LE, Minuzzi\u00a0L, MacQueen\u00a0G et\u00a0al (2017) The default mode network in healthy individuals: a\u00a0systematic review and meta-analysis. Brain Connec 7:25\u201333","journal-title":"Brain Connec"},{"key":"1722_CR45","doi-asserted-by":"publisher","first-page":"e077908","DOI":"10.1136\/bmjopen-2023-077908","volume":"14","author":"A Marquette","year":"2024","unstructured":"Marquette\u00a0A, Iraniparast\u00a0M, Hammond\u00a0D (2024) Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study. BMJ Open 14:e77908. https:\/\/doi.org\/10.1136\/bmjopen-2023-077908","journal-title":"BMJ Open"},{"key":"1722_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031113","author":"R Meccariello","year":"2020","unstructured":"Meccariello\u00a0R, Santoro\u00a0A, D\u2019Angelo\u00a0S et\u00a0al (2020) The epigenetics of the endocannabinoid system. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21031113","journal-title":"Int J Mol Sci"},{"key":"1722_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pscychresns.2009.12.004","volume":"182","author":"KL Medina","year":"2010","unstructured":"Medina\u00a0KL, Nagel\u00a0BJ, Tapert\u00a0SF (2010) Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res 182:152\u2013159","journal-title":"Psychiatry Res"},{"key":"1722_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/00952990.2017.1306746","volume":"44","author":"DA Nader","year":"2018","unstructured":"Nader\u00a0DA, Sanchez\u00a0ZM et\u00a0al (2018) Effects of regular cannabis use on neurocognition, brain structure, and function: a\u00a0systematic review of findings in adults. Am J Drug Alcohol Abuse 44:4\u201318","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1722_CR49","volume-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","author":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda","year":"2017","unstructured":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, & Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda (2017) The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press, US"},{"key":"1722_CR50","volume-title":"Der Substanzkonsum Jugendlicher und junger Erwachsener in Deutschland. Ergebnisse des Alkoholsurveys 2021 zu Alkohol, Rauchen, Cannabis und Trends. BZgA-Forschungsbericht","author":"B Orth","year":"2022","unstructured":"Orth\u00a0B, Merkel\u00a0C (2022) Der Substanzkonsum Jugendlicher und junger Erwachsener in Deutschland. Ergebnisse des Alkoholsurveys 2021 zu Alkohol, Rauchen, Cannabis und Trends. BZgA-Forschungsbericht. Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung, K\u00f6ln"},{"issue":"Suppl 1","key":"1722_CR51","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/pch\/pxaa018","volume":"25","author":"C Ouellet-Plamondon","year":"2020","unstructured":"Ouellet-Plamondon\u00a0C, Dubreucq\u00a0S, Jutras-Aswad\u00a0D (2020) Management of psychosis in the context of cannabis use: Beyond the chicken or the egg question. Paediatr Child Health 25(Suppl 1):S5\u2013S6. https:\/\/doi.org\/10.1093\/pch\/pxaa018","journal-title":"Paediatr Child Health"},{"key":"1722_CR52","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamapsychiatry.2015.1054","volume":"72","author":"D Pagliaccio","year":"2015","unstructured":"Pagliaccio\u00a0D, Barch\u00a0DM, Bogdan\u00a0R et\u00a0al (2015) Shared predisposition in the association between cannabis use and subcortical brain structure. JAMA Psychiatry 72:994\u20131001","journal-title":"JAMA Psychiatry"},{"key":"1722_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2013.12.008","volume":"51","author":"J Pujol","year":"2014","unstructured":"Pujol\u00a0J, Blanco-Hinojo\u00a0L, Batalla\u00a0A et\u00a0al (2014) Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users. J\u00a0Psychiatr Res 51:68\u201378","journal-title":"J Psychiatr Res"},{"key":"1722_CR54","first-page":"527","volume":"119","author":"C Rauschert","year":"2022","unstructured":"Rauschert\u00a0C, M\u00f6ckl\u00a0J, Seitz\u00a0NN et\u00a0al (2022) The Use of Psychoactive Substances in Germany. Dtsch \u00c4rztebl Int 119:527\u2013534","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1722_CR55","first-page":"1297","volume":"27","author":"J Renard","year":"2017","unstructured":"Renard\u00a0J, Rosen\u00a0LG, Loureiro\u00a0M et\u00a0al (2017) Adolescent cannabinoid exposure induces a\u00a0persistent sub-cortical hyper-dopaminergic state and associated molecular adaptations in the prefrontal cortex. Cereb Cortex 27:1297\u20131310","journal-title":"Cereb Cortex"},{"key":"1722_CR56","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fnins.2014.00361","volume":"8","author":"J Renard","year":"2014","unstructured":"Renard\u00a0J, Krebs\u00a0MO, Le Pen\u00a0G et\u00a0al (2014) Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front Neurosci 8:361","journal-title":"Front Neurosci"},{"key":"1722_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11757-019-00543-6","volume":"13","author":"P Roser","year":"2019","unstructured":"Roser\u00a0P (2019) Cannabis und Schizophrenie \u2013 Risikofaktoren, diagnostische Einordnung und Auswirkungen auf Verlauf und Prognose. Forens Psychiatr Psychol Kriminol 13:225\u2013232","journal-title":"Forens Psychiatr Psychol Kriminol"},{"key":"1722_CR58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.nbd.2014.09.015","volume":"73","author":"T Rubino","year":"2015","unstructured":"Rubino\u00a0T, Prini\u00a0P, Piscitelli\u00a0F et\u00a0al (2015) Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol Dis 73:60\u201369","journal-title":"Neurobiol Dis"},{"key":"1722_CR59","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","volume":"33","author":"T Rubino","year":"2008","unstructured":"Rubino\u00a0T, Vigano\u2019\u00a0D, Realini\u00a0N et\u00a0al (2008) Chronic delta 9\u2011tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33:2760\u20132771","journal-title":"Neuropsychopharmacology"},{"key":"1722_CR60","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s41386-019-0387-7","volume":"44","author":"LC Kruse","year":"2019","unstructured":"Kruse\u00a0LC, Cao\u00a0JK, Viray\u00a0K et\u00a0al (2019) Voluntary oral consumption of Delta(9)-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood. Neuropsychopharmacology 44:1406\u20131414","journal-title":"Neuropsychopharmacology"},{"key":"1722_CR61","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/0269881111405362","volume":"26","author":"T Rubino","year":"2012","unstructured":"Rubino\u00a0T, Zamberletti\u00a0E, Parolaro\u00a0D (2012) Adolescent exposure to cannabis as a\u00a0risk factor for psychiatric disorders. J\u00a0Psychopharmacol 26:177\u2013188","journal-title":"J Psychopharmacol"},{"key":"1722_CR62","volume-title":"Diagnostische Kriterien DSM-IV","author":"H Sa\u00df","year":"1998","unstructured":"Sa\u00df\u00a0H, Wittchen\u00a0HU, Zaudig\u00a0M, Houben\u00a0I (1998) Diagnostische Kriterien DSM-IV. Hogrefe, G\u00f6ttingen"},{"key":"1722_CR63","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neulet.2018.07.005","volume":"688","author":"JD Schmahmann","year":"2019","unstructured":"Schmahmann\u00a0JD (2019) The cerebellum and cognition. Neurosci Lett 688:62\u201375","journal-title":"Neurosci Lett"},{"key":"1722_CR64","unstructured":"Schwarzkopf\u00a0L, K\u00fcnzel\u00a0J, Murawski\u00a0M, Riemerschmid\u00a0C et\u00a0al (2023) Suchthilfe in Deutschland 2022. Jahresbericht der Deutschen Suchthilfestatistik (DSHS). M\u00fcnchen: IFT Institut f\u00fcr Therapieforschung. https:\/\/www.suchthilfestatistik.de\/fileadmin\/user_upload_dshs\/05_publikationen\/jahresberichte\/DSHS_DJ2022_Jahresbericht.pdf. Zugegriffen: 26. M\u00e4rz 2024"},{"key":"1722_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00115-017-0281-7","volume":"88","author":"M Soyka","year":"2017","unstructured":"Soyka\u00a0M, Preuss\u00a0U, Hoch\u00a0E (2017) Cannabisinduzierte St\u00f6rungen. Nervenarzt 88:311\u2013325","journal-title":"Nervenarzt"},{"key":"1722_CR66","unstructured":"UNODC (2023) World Drug Report. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2023.html"},{"key":"1722_CR67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/B978-0-12-800222-3.00011-5","volume":"86","author":"IC Weaver","year":"2014","unstructured":"Weaver\u00a0IC (2014) Integrating early life experience, gene expression, brain development, and emergent phenotypes: unraveling the thread of nature via nurture. Adv Genet 86:277\u2013307","journal-title":"Adv Genet"},{"key":"1722_CR68","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00213-015-4180-y","volume":"233","author":"MJ Wesley","year":"2016","unstructured":"Wesley\u00a0MJ, Lile\u00a0JA, Hanlon\u00a0CA et\u00a0al (2016) Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation. Psychopharmacology 233:1035\u20131044 (Berl)","journal-title":"Psychopharmacology"},{"key":"1722_CR69","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.drugalcdep.2015.05.046","volume":"153","author":"RR Wetherill","year":"2015","unstructured":"Wetherill\u00a0RR, Fang\u00a0Z, Jagannathan\u00a0K et\u00a0al (2015) Cannabis, cigarettes, and their co-occurring use: Disentangling differences in default mode network functional connectivity. Drug Alcohol Depend 153:116\u2013123","journal-title":"Drug Alcohol Depend"},{"key":"1722_CR70","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/00952990.2016.1245312","volume":"43","author":"SC Wollman","year":"2017","unstructured":"Wollman\u00a0SC, Alhassoon\u00a0OM, Hall\u00a0MG et\u00a0al (2017) Gray matter abnormalities in opioid-dependent patients: A\u00a0neuroimaging meta-analysis. Am J Drug Alcohol Abuse 43:505\u2013517","journal-title":"Am J Drug Alcohol Abuse"},{"key":"1722_CR71","first-page":"183","volume":"38","author":"NM Zahr","year":"2017","unstructured":"Zahr\u00a0NM, Pfefferbaum\u00a0A (2017) Alcohol\u2019s effects on the brain: neuroimaging results in humans and animal models. Alcohol Res 38:183\u2013206","journal-title":"Alcohol Res"},{"key":"1722_CR72","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00213-017-4803-6","volume":"235","author":"K Zimmermann","year":"2018","unstructured":"Zimmermann\u00a0K, Yao\u00a0S, Heinz\u00a0M et\u00a0al (2018) Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28\u00a0days of abstinence. Psychopharmacology 235:849\u2013859","journal-title":"Psychopharmacology"},{"key":"1722_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2010.07.004","volume":"170","author":"E Zurolo","year":"2010","unstructured":"Zurolo\u00a0E, Iyer\u00a0AM, Spliet\u00a0WG et\u00a0al (2010) CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies. Neuroscience 170:28\u201341","journal-title":"Neuroscience"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-024-01722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-024-01722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T13:03:23Z","timestamp":1725455003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-024-01722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1722"],"URL":"https:\/\/doi.org\/10.1007\/s00115-024-01722-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,12]]},"assertion":[{"value":"22 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"E.\u00a0Hoch und U.W.\u00a0Preuss geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}